Home › Funds › KCM Capital Inc › ABT

KCM Capital Inc position in ABT

ABBOTT LABORATORIES · Health Care

KCM Capital Inc reported holding 38,127 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 0.56% of its reported portfolio and ranking #32 among its reported holdings. KCM Capital Inc has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)38.13K sh
Reported value held$3.77M
Portfolio Weight0.56%
First reportedQ4 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How KCM Capital Inc's ABT position evolved

KCM Capital Inc first disclosed a stake in ABT in Q4 2025 at 38,128 shares (US$4.8M). Across 4 filings, KCM Capital Inc held the position steady without any share-count change. The most recent filing (Q3 2026) shows 38,127 shares valued at US$3.8M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 38.13K $4.78M New
Q1 2026 38.13K $3.91M Hold
Q2 2026 38.13K $3.46M Hold
Q3 2026 38.13K $3.77M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has KCM Capital Inc held ABT?

KCM Capital Inc has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is KCM Capital Inc's current position in ABT?

As of Q3 2026, KCM Capital Inc holds 38.13K shares of ABT (ABBOTT LABORATORIES), valued at $3.77M, representing 0.56% of its reported portfolio and ranking #32.

Has KCM Capital Inc been buying or selling ABT?

In the latest 13F filing (Q3 2026), KCM Capital Inc held unchanged its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.